SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-005970
Filing Date
2024-02-13
Accepted
2024-02-13 08:00:16
Documents
18
Period of Report
2024-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54379
2 ex10-1.htm EX-10.1 83079
3 ex10-2.htm EX-10.2 79022
4 ex10-3.htm EX-10.3 106628
5 ex99-1.htm EX-99.1 15019
  Complete submission text file 0001493152-24-005970.txt   567006

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE shph-20240207.xsd EX-101.SCH 3030
7 XBRL LABEL FILE shph-20240207_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE shph-20240207_pre.xml EX-101.PRE 22369
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3743
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 24622646
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)